Patient with Brain Tumor Responds Dramatically to Targeted Therapy
Cancer Currents: An NCI Cancer Research Blog,
A patient with a papillary craniopharyngioma saw his tumor shrink more than 80 percent after treatment with a targeted drug…
A patient with a papillary craniopharyngioma saw his tumor shrink more than 80 percent after treatment with a targeted drug…
Scientists have identified a mutated gene that causes a type of tenacious, benign brain tumor that can have devastating…
A genetic mutation associated with a number of cancers could also be responsible for papillary craniopharyngioma, a rare but…